adidas Response CL W - Lyserød - ID4289 - Rezet Store
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor | Journal of Medicinal Chemistry
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment - David W Dodick, Peter J Goadsby, Christian Lucas, Rigmor Jensen, Jennifer N Bardos,
Electrophysiological Studies in Migraine: A Comprehensive Review of Their Interest and Limitations - A Ambrosini, AM de Noordhout, PS Sándor, J Schoenen, 2003